Journal of Neurology, Neurosurgery & Psychiatry: 95 (9)

Editorial commentaries

Predicting how many people might receive treatment with new therapies for Alzheimer’s disease (11 June, 2024)
Benjamin R Underwood
Implications for driving based on the risk of seizures after ischaemic stroke (15 May, 2024) Free
Nishant K Mishra
CIDP trials and tribulations (10 May, 2024) Free
Simon Rinaldi

Neurodegeneration

Original research: Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease (11 June, 2024)
Ruth Dobson, Katherine Patterson, Reshad Malik, Uttara Mandal, Hina Asif, Ros Humphreys, Michael Payne, Eng O-Charoenrat, Lauren Huzzey, Adam Clare, Kate Green, Maija Morton, Catrin Sohrabi, Navreen Singh, Amirtha Pasupathy, Milan Patel, Sam Whiteman, Kate Maxmin, Nicholas Bass, Bhavya Gupta, Claudia Cooper, Charles Marshall, Rimona Sharon Weil, Catherine J Mummery
Original research: Patient-perceived progression in multiple system atrophy: natural history of quality of life (7 March, 2024)
Tiphaine Saulnier, Margherita Fabbri, Mélanie Le Goff, Catherine Helmer, Anne Pavy-Le Traon, Wassilios G. Meissner, Olivier Rascol, Cecile Proust-Lima, Alexandra Foubert-Samier
Original research: Clinicoradiological and neuropathological evaluation of primary progressive aphasia (21 March, 2024)
Dror Shir, Nick Corriveau-Lecavalier, Camilo Bermudez Noguera, Leland Barnard, Nha Trang Thu Pham, Hugo Botha, Joseph R Duffy, Heather M Clark, Rene L Utianski, David S Knopman, Ronald C Petersen, Bradley F Boeve, Melissa E Murray, Aivi T Nguyen, R Ross Reichard, Dennis W Dickson, Gregory S Day, Walter K Kremers, Neill R Graff-Radford, David T Jones, Mary M Machulda, Julie A Fields, Jennifer L Whitwell, Keith A Josephs, Jonathan Graff-Radford
Short report: NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study (19 January, 2024)
Christoph Linnemann, Carlo Wilke, David Mengel, Henrik Zetterberg, Carolin Heller, Jens Kuhle, Arabella Bouzigues, Lucy L Russell, Phoebe H Foster, Eve Ferry-Bolder, John Cornelis Van Swieten, Lize C Jiskoot, Harro Seelaar, Fermin Moreno, Barbara Borroni, Raquel Sánchez-Valle, Daniela Galimberti, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James Benedict Rowe, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Chris R Butler, Alexander Gerhard, Simon Ducharme, Isabelle L E Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan Daniel Rohrer, Matthis Synofzik
Short report: Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change (3 April, 2024)
Thomas D Parker, Chris Hardy, Sarah Keuss, William Coath, David M Cash, Kirsty Lu, Jennifer M Nicholas, Sarah-Naomi James, Carole Sudre, Sebastian Crutch, Doris-Eva Bamiou, Jason D Warren, Nick C Fox, Marcus Richards, Jonathan M Schott

Epilepsy

Original research: Implications for driving based on the risk of seizures after ischaemic stroke (15 May, 2024)
Kai Michael Schubert, Giulio Bicciato, Lucia Sinka, Laura Abraira, Estevo Santamarina, José Álvarez-Sabín, Carolina Ferreira-Atuesta, Mira Katan, Natalie Scherrer, Robert Terziev, Nico Döhler, Barbara Erdélyi-Canavese, Ansgar Felbecker, Philip Siebel, Michael Winklehner, Tim J von Oertzen, Judith N Wagner, Gian Luigi Gigli, Annacarmen Nilo, Francesco Janes, Giovanni Merlino, Mariarosaria Valente, María Paula Zafra-Sierra, Luis Carlos Mayor-Romero, Julian Conrad, S Evers, Piergiorgio Lochner, Frauke Roell, Francesco Brigo, Carla Bentes, Rita Peralta, Teresa Pinho e Melo, Mark R Keezer, John Sidney Duncan, Josemir W Sander, Barbara Tettenborn, Matthias Koepp, Marian Galovic

Neuromuscular

Original research: Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies (10 May, 2024)
Pietro Emiliano Doneddu, Dario Cocito, Raffaella Fazio, Luana Benedetti, Erdita Peci, Giuseppe Liberatore, Yuri Matteo Falzone, Francesco Germano, Francesca Gallia, Claudia Giannotta, Cinta Lleixà, Elisa Bianchi, Eduardo Nobile-Orazio
Original research: Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study (10 May, 2024)
Luis Querol, Jérôme De Sèze, Tina Dysgaard, Todd Levine, T Hemanth Rao, Michael Rivner, Hans-Peter Hartung, Peter Kiessling, Saori Shimizu, Dominika Marmol, Ali Bozorg, Anny-Odile Colson, Ute Massow, Filip Eftimov

Multiple sclerosis

Original research: T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination (28 March, 2024)
Niels J M Verstegen, Ruth R Hagen, Christine Kreher, Lisan H Kuijper, Jet van den Dijssel, Thomas Ashhurst, Laura Y L Kummer, Virginia Palomares Cabeza, Maurice Steenhuis, Mariël C Duurland, Rivka de Jongh, C Ellen van der Schoot, Veronique A L Konijn, Erik Mul, Katherine Kedzierska, Koos P J van Dam, Eileen W Stalman, Laura Boekel, Gertjan Wolbink, Sander W Tas, Joep Killestein, Theo Rispens, Luuk Wieske, Taco W Kuijpers, Filip Eftimov, Zoé L E van Kempen, S Marieke van Ham, Anja ten Brinke, Carolien E van de Sandt

Neuro-inflammation

Original research: Prevalence of autoimmune diseases in functional neurological disorder: influence of psychiatric comorbidities and biological sex (21 March, 2024)
Anna Joseph, Gaston Baslet, Mary A O’Neal, Ginger Polich, Irene Gonsalvez, Andrea N Christoforou, Barbara A Dworetzky, Primavera A Spagnolo
Short report: Validation of the international MOGAD panel proposed criteria: a single-centre US study (3 April, 2024)
Angeliki G Filippatou, Yana Said, Haiwen Chen, Eleni S Vasileiou, Gelareh Ahmadi, Elias S Sotirchos

Neuropsychiatry

Systematic review: Pain and functional neurological disorder: a systematic review and meta-analysis (21 February, 2024)
Moritz Steinruecke, Isabel Mason, Mairi Keen, Laura McWhirter, Alan J Carson, Jon Stone, Ingrid Hoeritzauer

PostScript

Letter: Effects of high-intensity interval training and moderate-intensity continuous training on non-motor symptoms in patients with Parkinson’s disease: a randomised pilot trial (28 March, 2024)
Ryul Kim, Seohee Choi, Nyeonju Kang, Kiwon Park, Heehyun Shin, Hanall Lee, Hyungwoo Lee, Jin-Sun Jun, Beomseok Jeon, Kyeongho Byun
Letter: Revisiting the jumping to conclusions bias in functional movement disorders (7 March, 2024)
Raquel Sainz-Amo, Jessenia Morillo-González, Jorge Gómez-Corral, Cristina Moreno, Araceli Alonso Cánovas, Juan Carlos Martinez Castrillo, Mark J Edwards, Daniel Hernández-Huerta, Isabel Pareés

Main menu

Table of contents

September 2024 - Volume 95 - 9

Editorial commentaries

Neurodegeneration

Epilepsy

Neuromuscular

Multiple sclerosis

Neuro-inflammation

Neuropsychiatry

PostScript

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

September 2024 - Volume 95 - 9

Editorial commentaries

Neurodegeneration

Epilepsy

Neuromuscular

Multiple sclerosis

Neuro-inflammation

Neuropsychiatry

PostScript

Issue Information